Skip to main content

Advertisement

Log in

Genistein Inhibit Cytokines or Growth Factor-Induced Proliferation and Transformation Phenotype in Fibroblast-Like Synoviocytes of Rheumatoid Arthritis

  • Published:
Inflammation Aims and scope Submit manuscript

Abstract

The purpose of this research is to study the effect of genistein on cytokines or growth factor-induced proliferation and transformation phenotype of rheumatoid arthritis fibroblast-like synoviocytes (RA-FLS). RA-FLS were primarily cultured. With respective stimulation of IL-1β, TNF-α, and EGF, genistein was applied to elucidate its effect on synoviocytes’ growth number, cell proliferation assay, cell cycle using cell counts, 3H-TdR incorporation and flow cytometry, the colony numbers under anchorage-independent condition, and the expression of MMP-2 and MMP-9 in synovial fibroblasts. EGF, IL-1β, and TNF-α increased 3H incorporation in RA-FLS, respectively. EGF augmented clone numbers of RA-FLS under anchorage-independent condition and not IL-1β and TNF-α. Genistein had an inhibitory role on cell number and 3H-TdR incorporation of RA-FLS stimulated with IL-1β, TNF-α and EGF; genistein arrested the cell cycle at G1 restriction point; genistein decreased colony numbers under anchorage-independent condition stimulated by EGF in serum condition. IL-1β or TNF-α increased expression of MMP-9 and MMP-2 in rheumatoid synoviocytes; EGF stimulated expression of MMP-9 but not of MMP-2; genistein suppressed production of MMP-9 more than MMP-2 induced by IL-1β or TNF-α; rMMP-9, rMMP-2, or their inhibitors had no effect on the 3H-TdR incorporation of synovial cells. Erk1/2 inhibitor (PD098 059) had obvious inhibitory effect on the 3H incorporation induced by TNF-α or IL-1β; inhibitors of JNK (SP600 125) had no significant effect on the 3H incorporation. While pretreatment with PD098059 had no marked inhibitory effect on MMP-9 expression induced by TNF-α or IL-1β, SP600125 decreased significantly the MMP-9 expression induced by TNF-α or IL-1β. Neither PD098059 nor SP600 125 could inhibit the MMP-2 expression induced by TNF-α or IL-1β. Genistein inhibited IL-1β, TNF-α or EGF-induced proliferation and MMP-9 expression in fibroblast-like synoviocytes of rheumatoid arthritis; the proliferation of RA-FLS was mediated by Erk1/2 but not JNK activation, while JNK activation was involved in the signal transduction pathway leading to MMP-9 expression in rheumatoid synoviocytes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9
Fig. 10

Similar content being viewed by others

REFERENCES

  1. Firestein, G.S. 2003. Evolving concepts of rheumatoid arthritis. Nature 423: 356–361.

    Article  PubMed  CAS  Google Scholar 

  2. Remmers, E.F., R. Lafyatis, G.K. Kumkumian, et al. 1990. Cytokines and growth regulation of synoviocytes from patients with rheumatoid arthritis and rats with streptococcal cell wall arthritis. Grow Factors 2: 179–188.

    CAS  Google Scholar 

  3. Lafyatis, R., E.F. Remmers, A.B. Roberts, et al. 1989. Anchorage-independent growth of synoviocytes from arthritic and normal joints. Stimulation by exogenous platelet-derived growth factor and inhibition by transforming growth factor-beta and retinoids. The Journal of Clinical Investigation 83: 1267–1276.

    Article  PubMed  CAS  Google Scholar 

  4. Qu, Z., C.H. Garcia, L.M. O’Rourke, S.R. Planck, M. Kohli, and J.T. Rosenbaum. 1994. Local proliferation of fibroblast-like synoviocytes contributes to synovial hyperplasia: Results of proliferating cell nuclear antigen, cyclin, c-myc, and nucleolar organizer region staining. Arthritis and Rheumatism 37: 212–220.

    Article  PubMed  CAS  Google Scholar 

  5. Müller-Ladner, U., J. Kriegsmann, R.E. Gay, and S. Gay. 1995. Oncogenes in rheumatoid arthritis. Rheumatic Diseases Clinics of North America 21: 675–690.

    PubMed  Google Scholar 

  6. Firestein, G.S., K. Nguyen, K.R. Aupperle, M. Yeo, D.L. Boyle, and N.J. Zvaifler. 1996. Apoptosis in rheumatoid arthritis: p53 overexpression in rheumatoid arthritis synovium. American Journal of Pathology 149: 2143–2151.

    PubMed  CAS  Google Scholar 

  7. Muller-Ladner, U., J. Kriegsmann, B.N. Franklin, S. Matsomoto, T. Geiler, R.E. Gay, et al. 1996. Synovial fibroblasts of patients with rheumatoid arthritis attach to and invade normal human cartilage when engrafted into SCID mice. American Journal of Pathology 49: 1607–1615.

    Google Scholar 

  8. Pap, T., I. Meinecke, U. Muller-Ladner, and S. Gay. 2005. Are fibroblasts involved in joint destruction? Annals of the Rheumatic Diseases 64(Suppl. 4): iv52–iv54.

    Article  PubMed  CAS  Google Scholar 

  9. Tanos, V., A. Brzezinski, O. Drize, N. Strauss, and T. Peretz. 2002. Synergistic inhibitory effects of genistein and tamoxifen on human dysplastic and malignant epithelial breast cells in vitro. European Journal of Obstetrics, Gynecology, and Reproductive Biology 102(2): 188–194.

    Article  PubMed  CAS  Google Scholar 

  10. Fotsis, T., M.S. Pepper, E. Aktas, S. Breit, S. Rasku, H. Adlercreutz, K. Wahala, R. Montesano, and L. Schweigerer. 1997. Flavonoids, dietary-derived inhibitors of cell proliferation and in vitro angiogenesis. Cancer Research 57: 2916–2921.

    PubMed  CAS  Google Scholar 

  11. Lamartiniere, C.A. 2000. Protection against breast cancer with genistein: A component of soy. American Journal of Clinical Nutrition 71: 1708S–1709S.

    Google Scholar 

  12. Arnet, F.C., S.M. Edworthy, D.A. Bloch, et al. 1988. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis and Rheumatism 31: 3152–3241.

    Google Scholar 

  13. James, W.P. 2008. The fundamental drivers of the obesity epidemic. Obesity Reviews 9(Suppl. 1): 6–13.

    Article  PubMed  Google Scholar 

  14. Magee, P.J., and I.R. Rowland. 2004. Phyto-oestrogens, their mechanism of action: current evidence for a role in breast and prostate cancer. British Journal of Nutrition 91: 513–531.

    Article  PubMed  CAS  Google Scholar 

  15. Lamartiniere, C.A. 2000. Protection against breast cancer with genistein: a component of soy. American Journal of Clinical Nutrition 71: 1705S–1707S.

    PubMed  CAS  Google Scholar 

  16. Cappelletti, V., L. Fioravanti, P. Miodini, and G. Di Fronzo. 2000. Genistein blocks breast cancer cells in the G(2)M phase of the cell cycle. Journal of Cellular Biochemistry 79(4): 594–600.

    Article  PubMed  CAS  Google Scholar 

  17. Lu, H., T. Sun, L. Yao, and Y. Zhang. 2000. Role of protein tyrosine kinase in IL-1β induced activation of mitogen- activated protein kinase in fibroblast-like synoviocytes of rheumatoid arthritis. Chinese Medical Journal 113(10): 872–876.

    PubMed  CAS  Google Scholar 

  18. Charoenrat, P., H. Modjtahedi, P. Rhys-Evans, W. Court, G. Box, and S. Eccles. 2000. Epidermal growth factor-like ligands differentially up-regulate matrix metalloproteinase 9 in head and neck squamous carcinoma cells. Cancer Research 60: 1121–1128.

    Google Scholar 

  19. Liu, Z., and J. Klominek. 2003. Regulation of matrix metalloprotease activity in malignant mesothelioma cell lines by growth factors. Thorax 58: 198–203.

    Article  PubMed  CAS  Google Scholar 

  20. Nutt, J., G. Durkan, J. Mellon, and J. Lunec. 2003. Matrix metalloproteinases (MMPs) in bladder cancer: The induction of MMP9 by epidermal growth factor and its detection in urine. BJU International 91: 99–104.

    Article  PubMed  CAS  Google Scholar 

  21. Gonzalez, R., L. Devoto, A. Campana, and P. Bischof. 2001. Effects of leptin, interleukin-1alpha, interleukin-6, and transforming growth factor-beta on markers of trophoblast invasive phenotype: integrins and metalloproteinases. Endocrine 15: 157–164.

    Article  PubMed  CAS  Google Scholar 

  22. Bischof, P., K. Truong, and A. Campana. 2003. Regulation of trophoblastic gelatinases by proto-oncogenes. Placenta 24: 155–163.

    Article  PubMed  CAS  Google Scholar 

  23. Unemori, E.N., M.S. Hibbs, and E.P. Amento. 1991. Constitutive expression of a 92KD gelantinase (type V collagenase) by rheumatoid synovial fibroblast and its induction in normal human fibroblasts by inflammatory cytokines. The Journal of Clinical Investigation 88: 1656–1662.

    Article  PubMed  CAS  Google Scholar 

  24. Sheu, B.C., S.M. Hsu, H.N. Ho, H.C. Lien, S.C. Huang, and R.H. Lin. 2001. A novel role of metalloproteinase in cancer-mediated immunosuppression. Cancer Research 61: 237–242.

    PubMed  CAS  Google Scholar 

  25. Hartland, S.N., F. Murphy, R.L. Aucott, et al. 2009. Active matrix metalloproteinase-2 promotes apoptosis of hepatic stellate cells via the cleavage of cellular N-cadherin. Liver International 29: 966–978.

    Article  PubMed  CAS  Google Scholar 

  26. Wielockx, B., K. Lannoy, S.D. Shapiro, et al. 2001. Inhibition of matrix metalloproteinases blocks lethal hepatitis and apoptosis induced by tumor necrosis factor and allows safe antitumor therapy. Nature Medicine 7: 1202–1208.

    Article  PubMed  CAS  Google Scholar 

  27. Sato, H., and M. Seiki. 1993. Regulatory mechanism of 92-kDa type IV collagenase gene expression which is associated with invasiveness of tumor cells. Oncogene 8: 395–405.

    PubMed  CAS  Google Scholar 

  28. Wiehler, S., S.L. Cuvelier, S. Chakrabarti, and K.D. Patel. 2004. p38 MAP kinase regulates rapid matrix metalloproteinase-9 release from eosinophils. Biochemical and Biophysical Research Communications 315: 463–470.

    Article  PubMed  CAS  Google Scholar 

  29. Holvoet, S., C. Vincent, D. Schmitt, and M. Serres. 2003. The inhibition of MAPK pathway is correlated with down-regulation of MMP-9 secretion induced by TNF-alpha in human keratinocytes. Experimental Cell Research 290: 108–119.

    Article  PubMed  CAS  Google Scholar 

  30. Han, Z., D.L. Boyle, L. Chang, B. Bennett, M. Karin, L. Yang, et al. 2001. c-Jun N-terminal kinase is required for metalloproteinase expression and joint destruction in inflammatory arthritis. The Journal of Clinical Investigation 108: 73–81.

    PubMed  CAS  Google Scholar 

  31. Schultze-Mosgau, M.H., I.L. Dale, T.W. Gant, J.K. Chipman, D.J. Kerr, and A. Gescher. 1998. Regulation of c-fos transcription by chemopreventive isoflavonoids and lignans in MDA-MB-468 breast cancer cells. European Journal of Cancer 34(9): 1425–1431.

    Article  PubMed  CAS  Google Scholar 

  32. Huang, S., M. Koneiczkowski, and J.R. Sedor. 1994. Redox regulation of cytosolic tyrosine kinases by IL-1α(Abstract). Journal of the American Society of Nephrology 5: 716.

    Google Scholar 

Download references

Acknowledgment

This work was supported by a grant from the National Natural Science Foundation of China (no. 30801160)

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Tiezheng Sun.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zhang, Y., Dong, J., He, P. et al. Genistein Inhibit Cytokines or Growth Factor-Induced Proliferation and Transformation Phenotype in Fibroblast-Like Synoviocytes of Rheumatoid Arthritis. Inflammation 35, 377–387 (2012). https://doi.org/10.1007/s10753-011-9365-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10753-011-9365-x

KEY WORDS

Navigation